正式认可的高级社区药剂师的实践:从全球文献的范围审查
Kartika Citra Dewi Permata Sari1, Shaikha Jabor Alnaimi2, Cate Whittlesea3
1Research Department of Practice and Policy, University College London School of Pharmacy, University College London, London, United Kingdom; Health Innovation Study and Policy Research Cluster, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.
Research in social & administrative pharmacy : RSAP
|February 17, 2026
概括
先进的社区药剂师 (ACP) 提供了扩展的临床服务,但他们的正式认可和实践,特别是在研究和教育方面,需要在全球范围内进一步发展. 在全球范围内,关于非洲,非洲和中东的证据有限,特别是来自中低收入国家的证据.
科学领域:
- 制药实践 制药实践 制药实践
- 医疗保健服务研究 医疗服务研究
- 全球健康 全球健康
背景情况:
- 有限的综合证据存在于高级社区药剂师 (ACP) 的正式认可和实践.
- 本次审查涉及有关正式承认的非洲和非洲国家/地区实践的全球证据.
研究的目的:
- 探索和综合全球证据,正式认可的先进社区药剂师 (ACP) 的实践.
主要方法:
- 根据JBI和PRISMA指南进行了范围审查.
- 使用国际制药联合会框架 (专业实践,领导,研究,教育) 定义了高级实践.
- 正式承认被定义为授权机构对注册后的确认;搜索了12个数据库 (2004-2024年).
主要成果:
- 包括来自六个高收入国家的63项研究,主要是加拿大和美国.
- 正式认可的ACP提供了临床服务,如处方,疫苗接种和药物审查.
- 很少有研究报告了非洲和非洲国家在研究和教育方面的做法;挑战包括薪酬和记录访问,而促进者包括正式承认和培训.
结论:
- 先进的社区药剂师 (ACP) 提高了公众获得临床服务的机会.
- 来自中低收入国家的非洲,非洲和非洲国家 (ACP) 的正式承认和实践代表性不足.
- 需要进一步的研究,以使先进的实践变得可行,报告认可机制,并让利益相关者参与到ACP角色发展中,特别是在教育和研究方面.
相关概念视频
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Analysis of Population Pharmacokinetic Data
829
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
829
Pharmaceutical Poisoning: Potential Scenarios
19
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
19
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Bioavailability Study Design: Healthy Subjects Versus Patients
165
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
165


